Bio Medical Pharma Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Bio Medical Pharma Sp. z o.o. (Poland)

Main Activities: Electronic Shopping and Mail-Order Houses

Secondary Activities: All Other Miscellaneous Food Manufacturing | Pharmaceutical Preparation Manufacturing | Toilet Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | All Other Professional, Scientific, and Technical Services | Packaging and Labeling Services | Other Personal and Household Goods Repair and Maintenance

Full name: Bio Medical Pharma Sp. z o.o.

Profile Updated: December 16, 2023

Bio Medical Pharma is a company that specializes in dietary supplements, including the Licur 7000 with vitamin D, which is known for its increased biodisponibility.

Headquarters
Ul. Kaczencowa 10F
Lodz; Lodzkie; Postal Code: 91-214

Contact Details: Purchase the Bio Medical Pharma Sp. z o.o. report to view the information.

Website: http://www.bmpharma.pl/

Basic Information

Total Employees:

Purchase the Bio Medical Pharma Sp. z o.o. report to view the information.

Outstanding Shares:

Purchase the Bio Medical Pharma Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Bio Medical Pharma Sp. z o.o. report to view the information.

Incorporation Date:

January 02, 2014

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Bio Medical Pharma Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-35.1%▼

Total operating revenue

-35.26%▼

Operating profit (EBIT)

-94.02%▼

EBITDA

-93.26%▼

Net Profit (Loss) for the Period

-94.03%▼

Total assets

-9.61%▼

Total equity

0.85%▲

Operating Profit Margin (ROS)

-10.48%▼

Net Profit Margin

-8.48%▼

Return on Equity (ROE)

-13.39%▼

Quick Ratio

1.21%▲

Cash Ratio

0.49%▲

Similar companies